Using genome-wide sequencing methods and methods for evaluating CFTR channel activity, the group of Baldassarri et al. found that carriers of one pathogenic allele of the CFTR gene have a higher risk of severe COVID-19 and 14-day death compared to people without pathogenic variants of the CFTR gene. The gene discussed is CFTR; the disease is COVID-19.